1. Studies on the hemorrhagic sweet clover disease. V. Identification and synthesis of the hemorrhagic agent;Stahmann;J Biol Chem,1941
2. Stroke prevention in atrial fibrillation study;Circulation,1991
3. Effectiveness and safety of dabigatran, rivaroxaban, and apixaban versus warfarin in nonvalvular atrial fibrillation;Xiaoxi;J Am Heart Assoc,2016
4. IMS Health. IMS data US National Prescription Audit; MAT (moving annual total) 2017-2018. http://www.imshealth.com/vgnexttemplating/v/index.jsp?vgnextoid=63750991070ad310VgnVCM1000001b9e2ca2RCRD&vgnextfmt=default. Accessed Feb 1, 2019.
5. Warfarin reversal emerging as the major indication for fresh frozen plasma use at a tertiary care hospital;Ozgonenel;Am J Hematol,2007